Global Impact of the COVID-19 Pandemic on Cerebral Venous
Thrombosis and Mortality

J 2022

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER et. al.

Základní údaje

Originální název

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Autoři

NGUYEN, Thanh N (garant), Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK (203 Česká republika, domácí), Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ (203 Česká republika), Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA

Vydání

JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2022, 2287-6391

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Korejská republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

STROKE

Impakt faktor

Impact factor: 8.200

Kód RIV

RIV/00216224:14110/22:00127760

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.5853/jos.2022.00752

UT WoS

000812327500008

Klíčová slova česky

COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke

Klíčová slova anglicky

COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke

Štítky

14110127, Excelence Science, FNUSA, MU, RIV, rivok, Stroke, user, článek v časopise

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 5. 4. 2023 14:01, Mgr. Tereza Miškechová

Anotace

V originále

Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.

Návaznosti

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. JOURNAL OF STROKE. SEOUL: KOREAN STROKE SOC, 2022, roč. 24, č. 2, s. 256-265. ISSN 2287-6391. Dostupné z: https://dx.doi.org/10.5853/jos.2022.00752.

@article{2244034,
   author = {Nguyen, Thanh N and Qureshi, Muhammad M and Klein, Piers and Yamagami, Hiroshi and Abdalkader, Mohamad and Mikulík, Robert and Sathya, Anvitha and Mansour, Ossama Yassin and Czlonkowska, Anna and Lo, Hannah and Field, Thalia S and Charidimou, Andreas and Banerjee, Soma and Yaghi, Shadi and Siegler, James E and Šedová, Petra and Kwan, Joseph and Aguiar, de Sousa Diana and Demeestere, Jelle and Inoa, Violiza and Omran, Setareh Salehi and Zhang, Liqun and Michel, Patrik and Strambo, Davide and Marto, Joao Pedro and Nogueira, Raul G},
   article_location = {SEOUL},
   article_number = {2},
   doi = {http://dx.doi.org/10.5853/jos.2022.00752},
   keywords = {COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke},
   language = {eng},
   issn = {2287-6391},
   journal = {JOURNAL OF STROKE},
   title = {Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194544/pdf/jos-2022-00752.pdf},
   volume = {24},
   year = {2022}
}

TY  - JOUR
ID  - 2244034
AU  - Nguyen, Thanh N - Qureshi, Muhammad M - Klein, Piers - Yamagami, Hiroshi - Abdalkader, Mohamad - Mikulík, Robert - Sathya, Anvitha - Mansour, Ossama Yassin - Czlonkowska, Anna - Lo, Hannah - Field, Thalia S - Charidimou, Andreas - Banerjee, Soma - Yaghi, Shadi - Siegler, James E - Šedová, Petra - Kwan, Joseph - Aguiar, de Sousa Diana - Demeestere, Jelle - Inoa, Violiza - Omran, Setareh Salehi - Zhang, Liqun - Michel, Patrik - Strambo, Davide - Marto, Joao Pedro - Nogueira, Raul G
PY  - 2022
TI  - Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
JF  - JOURNAL OF STROKE
VL  - 24
IS  - 2
SP  - 256-265
EP  - 256-265
PB  - KOREAN STROKE SOC
SN  - 22876391
KW  - COVID-19
KW  - Cerebral venous thrombosis
KW  - Vaccine-induced immune thrombotic thrombocytopenia
KW  - Mortality
KW  - SARS-CoV-2
KW  - Stroke
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194544/pdf/jos-2022-00752.pdf
N2  - Since the first case in December 2019, coronavirus disease 2019 (COVID-19) has been responsible for more than 340 million infections and over 5.5 million deaths.1 Though most of the morbidity and mortality associated with COVID-19 is related to pulmonary complications, the disease has had wide-ranging systemic effects, including a range of neurological manifestations2,3 and disruption of coagulation homeostasis.4-7 This disruption in normal coagulation may trigger abnormal clotting events such as venous thromboembolism and stroke.8-10 Cerebral venous thrombosis (CVT) is a rare cause of stroke caused by the formation of clots in the brain’s venous system. The incidence of CVT has been reported to increase over the last decade, either from changing risk factors or improved detection.11-13 Compared to other forms of stroke, the incidence of CVT is more common in younger patients and women. CVT generally has a favorable prognosis with a good 90-day neurological outcome seen in greater than 80% of patients.
ER  -

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. \textit{JOURNAL OF STROKE}. SEOUL: KOREAN STROKE SOC, 2022, roč.~24, č.~2, s.~256-265. ISSN~2287-6391. Dostupné z: https://dx.doi.org/10.5853/jos.2022.00752.

Podrobný výpis o publikaci